0001214659-20-007348.txt : 20200818
0001214659-20-007348.hdr.sgml : 20200818
20200818185210
ACCESSION NUMBER: 0001214659-20-007348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200817
FILED AS OF DATE: 20200818
DATE AS OF CHANGE: 20200818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniels Mark
CENTRAL INDEX KEY: 0001753840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 201114881
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-49480.xml
PRIMARY DOCUMENT
X0306
4
2020-08-17
0001581280
Twist Bioscience Corp
TWST
0001753840
Daniels Mark
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
See Remarks
Common Stock
2020-08-17
4
M
false
20994
5.95
A
74712
D
Common Stock
2020-08-17
4
S
false
5994
67.00
D
68718
D
Common Stock
2020-08-17
4
S
false
7500
68.00
D
61218
D
Common Stock
2020-08-17
4
S
false
7500
69.00
D
53718
D
Employee Stock Option (right to buy)
5.95
2020-08-17
4
M
false
20994
0
D
2026-08-29
Common Stock
20994
10878
D
The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary
/s/ William Solis, as Attorney-in-Fact for Mark Daniels
2020-08-18